v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating Expenses:        
Research and development expenses $ 888,013 $ 1,210,436 $ 1,942,622 $ 1,897,350
General and administrative expenses 930,779 948,574 2,176,415 2,510,926
Total Operating Expenses 1,818,792 2,159,010 4,119,037 4,408,276
Loss From Operations (1,818,792) (2,159,010) (4,119,037) (4,408,276)
Other Income (Expense)        
Interest income 5,182 24,603 28,614 32,981
Other income 2,500 2,500
Warrant modification expense (441,763)
Total other income (expense) 7,682 24,603 31,114 (408,782)
Loss Before Provision For Income Taxes (1,811,110) (2,134,407) (4,087,923) (4,817,058)
Provision for income taxes
Net Loss $ (1,811,110) $ (2,134,407) $ (4,087,923) $ (4,817,058)
Net loss per share, basic and diluted $ (0.16) $ (0.21) $ (0.38) $ (0.52)
Weighted average shares, basic and diluted 11,292,037 10,223,704 10,894,681 9,241,828

Source